Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems.

guest :: login DZNEPUB
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help

Home > Publications Database > Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems. > Access to Fulltext

Information
Files

Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems. - DZNE-2022-00405

Main document file(s):

Similar records

DZNEPUB :: :: :: ::
Powered by v1.1.7 |
Maintained by

Impressum | Data Privacy Policy